Trial reportBMC complementary medicine and therapies2026
Modified Baduanjin improves balance function in subacute stroke survivors: a randomized controlled study.
Trial report in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundBalance dysfunction is common after stroke, yet subacute patients often are often unable to perform traditional Baduanjin exercises due to severe motor impairments. The objective of this study was to determine whether a modified Baduanjin program, adapted to sitting and standing positions, could improve balance function in subacute stroke survivors beyond conventional rehabilitation.
methodsFifty-four subacute stroke patients were randomly assigned to receive either conventional rehabilitation plus modified Baduanjin (40 min daily, n = 27) or conventional rehabilitation alone (80 min daily, n = 27), five days per week for six weeks. The primary outcome was performance on the Berg Balance Scale (BBS); secondary outcomes included lower extremity motor function (FMA-LE), functional independence (MBI), and dynamic balance during walking assessed by 3D motion analysis.
resultsPatients in the modified Baduanjin group demonstrated significantly greater improvements in balance (BBS: between-group difference 6.1 points, 95% CI: 2.5–9.7, p = 0.001), lower extremity motor function (FMA-LE: 2.3 points, p = 0.019), and functional independence (MBI: 8.4 points, p < 0.001) compared to controls. Dynamic balance during walking, as measured by mediolateral sway amplitude, also showed greater improvement in the intervention group (p = 0.015). The intervention was associated with high adherence (94%) and was well tolerated, with no serious adverse events reported.
conclusionModified Baduanjin is expected to become a safe and viable adjunctive intervention that could help patients with subacute stroke improve their balance in addition to conventional rehabilitation. These preliminary findings warrant confirmation by multicenter trials on a larger scale.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.